Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research
- PMID: 39535468
- PMCID: PMC11667558
- DOI: 10.1002/alz.14312
Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research
Abstract
Frontotemporal dementia (FTD) is one of the leading causes of young-onset dementia before age 65, typically manifesting as abnormal behavior (in behavioral variant FTD) or language impairment (in primary progressive aphasia). Although FTD affects all populations across the globe, knowledge regarding the pathophysiology and genetics derives primarily from studies conducted in North America and Western Europe. Globally, biomedical research for FTD is hindered by variable access to diagnosis, discussed in this group's earlier article, and by reduced access to expertise, funding, and infrastructure. This perspective paper was produced by two professional interest areas of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) and discusses the field's current status on the cross-cultural aspects of basic and translational research in FTD (including that focused on epidemiology, genetics, biomarkers, and treatment). It subsequently provides a summary of gaps and needs to address the disparities and advance global FTD biomedical research.
Keywords: biomarkers; cultural diversity; epidemiology; ethnicity; frontotemporal dementia; genetics; infrastructure.
© 2024 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
S.F. receives royalties on two neuropsychological tests (mVAT and FDT; Hogrefe). N.G. receives consulting fees from Blue Cross Blue Shield Association. C.U.O. receives consulting fees from Acadia Pharmaceuticals, Reata Pharmaceuticals, Otsuka Pharmaceuticals, Eli Lily and Company, Alexion Pharmaceuticals, Lykis Therapeutics, and Zeyra Therapeutics. All other authors report no conflicts of interest. Author disclosures are available in the supporting information.
Figures
References
Publication types
MeSH terms
Grants and funding
- U54NS092089 to N.G./GF/NIH HHS/United States
- U19 AG063911/AG/NIA NIH HHS/United States
- P30 AG062422/AG/NIA NIH HHS/United States
- #LSHM20106 to S.F./Health Holland, Topsector Life Sciences & Health
- R01 AG057234/AG/NIA NIH HHS/United States
- U01 AG045390/AG/NIA NIH HHS/United States
- R01AG074302 to G.B./National Institutes of Health's/National Institute on Aging
- AACSF-22-849085 to H.U./ALZ/Alzheimer's Association/United States
- R01AG21051 to A.S./National Institutes of Health's/National Institute on Aging
- R01AG067428 to G.B./National Institutes of Health's/National Institute on Aging
- R01AG075775 to J.A-U./National Institutes of Health's/National Institute on Aging
- R01 AG075775/AG/NIA NIH HHS/United States
- ID15150012 to A.S./FONDAP
- U19 AG074865/AG/NIA NIH HHS/United States
- R01 AG068183/AG/NIA NIH HHS/United States
- A2021142S to G.B./BrightFocus Foundation
- K01 AG070376/AG/NIA NIH HHS/United States
- R01AG075775 to A.S./National Institutes of Health's/National Institute on Aging
- R01 AG080469/AG/NIA NIH HHS/United States
- Association for Frontotemporal Dementia (AFTD)
- Robert and Nancy Hall Brain Research Fund
- R01 AG062588/AG/NIA NIH HHS/United States
- 1231839 to A.S./ANID/ Fondecyt Regular
- PI21/00791 to I.I.-G./Instituto de Salud Carlos III
- U01AG045390 to N.G./GF/NIH HHS/United States
- U54NS123985 to J.S.Y./NIH/National Institute of Neurological Disorders and Stroke (NINDS)
- JR20/0018 to I.I.-G./Instituto de Salud Carlos III
- R01AG056466 to G.B./National Institutes of Health's/National Institute on Aging
- ES/W006405/1 to A.S.-G./UK Research and Innotation Healthy Ageing Challenge Catalyst Award
- K23 DC018021/DC/NIDCD NIH HHS/United States
- Velux foundation
- AACSF-21-850193 to I.I.-G./ALZ/Alzheimer's Association/United States
- U54 NS123985/NS/NINDS NIH HHS/United States
- W81XWH2110437 to K.N./Department of Defense
- R01AG080469 to B.L.T./National Institutes of Health's/National Institute on Aging
- R01 AG083840/AG/NIA NIH HHS/United States
- Health Resources and Service Administration to D.M.
- #73305095007 to S.F./ZONMW_/ZonMw/Netherlands
- Agencia Nacional de Investigación y Desarollo (ANID)
- R01AG057234 to J.A-U./National Institutes of Health's/National Institute on Aging
- R01AG083840 to B.L.T./National Institutes of Health's/National Institute on Aging
- R01AG062588 to J.S.Y./National Institutes of Health's/National Institute on Aging
- GNT1158762 to F.K./National Health and Medical Research Council Career Development Fellowship
- COV-LT2-0014 to A.S.-G./National Institute for Health Research
- R01AG21051 to J.A-U./National Institutes of Health's/National Institute on Aging
- Rainwater Charitable Foundation's Tau Consortium
- PPP-allowance to S.F./Health Holland, Topsector Life Sciences & Health
- R01 AG080396/AG/NIA NIH HHS/United States
- R01AG068183 to G.B./National Institutes of Health's/National Institute on Aging
- R01 AG074302/AG/NIA NIH HHS/United States
- NIH/Center for Alzheimer's and Related Dementies (CARD)
- Rainwater Charitable Foundation
- Bluefield Project to Cure Frontotemporal Dementia
- R01AG057234 to A.S./National Institutes of Health's/National Institute on Aging
- IDEX Fellowship
- U19AG063911 to N.G./GF/NIH HHS/United States
- U54 NS092089/NS/NINDS NIH HHS/United States
- R01 AG067428/AG/NIA NIH HHS/United States
- SG-20-725707 to A.S./ALZ/Alzheimer's Association/United States
- Mary Oakley Foundation
- R01 AG056466/AG/NIA NIH HHS/United States
- R01AG057234 to J.S.Y./National Institutes of Health's/National Institute on Aging
- P30AG062422 to J.S.Y./National Institutes of Health's/National Institute on Aging
- Global Brain Health Institute
LinkOut - more resources
Full Text Sources
Miscellaneous
